Clinical Diagnosis and Treatment of Atopic Dermatitis

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".

Deadline for manuscript submissions: 20 May 2024 | Viewed by 1078

Special Issue Editor


E-Mail Website
Guest Editor
Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Interests: atopic dermatitis; pruritus; vitiligo; urticaria; eczema

Special Issue Information

Dear Colleagues,

Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory skin condition with an immunologic mechanism that commonly affects children but is increasing in the adult population. The diagnosis of atopic dermatitis is primarily based on a thorough clinical evaluation, which includes a detailed medical history and physical examination. The characteristic symptoms of atopic dermatitis include dry, itchy, and inflamed skin, along with a history of recurrent flare-ups. We also need to evaluate the associated comorbidities. The management of atopic dermatitis should be individualized based on the severity and specific needs of each patient. Regular follow-up visits with healthcare providers are important to monitor the response to treatment, adjust the treatment plan as needed, and address any concerns or questions. Ongoing research and advancements in the field continue to shape the management strategies for atopic dermatitis, with a focus on personalized and targeted therapies. This Special Issue is open for submissions of papers that aim to bring together the most relevant scientific research on atopic dermatitis.

Dr. Esther Serra-Baldrich
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atopic dermatitis
  • pruritus
  • treatment
  • emerging therapies
  • pathophysiology
  • immunologic mechanism
  • cutaneous barrier
  • comorbidities

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

15 pages, 991 KiB  
Systematic Review
Should Emollients Be Recommended for the Prevention of Atopic Dermatitis?—New Evidence and Current State of Knowledge
by Magdalena Grześk-Kaczyńska, Justyna Petrus-Halicka, Szymon Kaczyński, Zbigniew Bartuzi and Natalia Ukleja-Sokołowska
J. Clin. Med. 2024, 13(3), 863; https://doi.org/10.3390/jcm13030863 - 1 Feb 2024
Cited by 2 | Viewed by 937
Abstract
Introduction: Atopic dermatitis (AD) is a chronic, pruritic skin disease with complex pathogenesis, which affects about 43 million children aged 1–4 years. One of the most known methods of alleviating symptoms of AD is emollient treatment, which varies depending on formulation and additional [...] Read more.
Introduction: Atopic dermatitis (AD) is a chronic, pruritic skin disease with complex pathogenesis, which affects about 43 million children aged 1–4 years. One of the most known methods of alleviating symptoms of AD is emollient treatment, which varies depending on formulation and additional active ingredients. There is some evidence that emollients could be used in AD prevention in high-risk children. Materials and methods: A search of the literature from Cochrane Library, PubMed and Medline was conducted between August and September 2023 with the following keywords: “atopic dermatitis”, “emollients”, and “prevention”. Only randomised clinical trials published in the last 5 years were included into the meta-analysis. Results: Considering the inclusion criteria only 11 randomized clinical trials were taken into account, and six of them proved lack of effect of emollients in the prevention of atopic dermatitis among neonates from AD risk groups. Conclusions: Emollient treatment has a good safety profile and most of the ingredients used in formulations are nonirritant for sensitive newborn and infant skin. There is some evidence of the positive effects of emollient treatment in prevention of AD in predisposed populations. The relatively high cost of emollient treatment (vs regular infant skin-care routine) would support the necessity for further evaluation of their effectiveness in nonpredisposed populations. Full article
(This article belongs to the Special Issue Clinical Diagnosis and Treatment of Atopic Dermatitis)
Show Figures

Figure 1

Back to TopTop